Saturday, September 26, 2026
MiningNewsTerminal
Saturday, September 26, 2026 Admin

MN.V ·

Manganese X Subsidiary and JV Partner, PureBiotic AIR® Provide Year-End Update on the Progress of Regulatory and Certification Registrations

Partnerships & JV

Page 1 of 4

Manganese X Subsidiary and JV Partner, PureBiotic AIR® Provide

Year-End Update on the Progress of Regulatory and Certification

Registrations

Montréal, Québec, Canada, January 13 , 2022, Manganese X Energy

Corp. (TSXV: MN) (FSE: 9SC) (OTCQB: MNXXF) (“Manganese X”,

“MN”, or the “Company”) is pleased to announce that its wholly owned

subsidiary, Disruptive Battery Corp. (DBC) in conjunction with its US JV Partner,

PureBioticAIR, Inc. (“PureBiotic”) continues to advance the certification and

regulatory registrations of its products.

Work also progressed on the deconstruction of biofilm, which is calculated by

the Center for Disease Control (CDC) to be a factor in 80 per cent of all

infections. The deconstruction of biofilm reduces the risk of infection from

pathogenic bacteria and viruses, including SARS -CoV-2 virus, cause of the

COVID-19 Pandemic.

Current Regulatory Registrations:

The Company has employed additional resources to expedite the number of

Food and Drug Administration (FDA), Environmental Protection Agency (EPA)

and other registrations and certifications currently in progress. PureBiotic is also

continuing to expand the Company’s Trade Mark registr ations to countries

around the World. The Company’s Trade Mark has already been granted in the

Americas, Europe and China.

This important work is coordinated by the CEO of PureBiotic AIR ®, Lino G

Morris, along with the Company’s regulatory attorney, K. Steinman, Esq.. Mr.

Steinman formerly worked for the US Government for years in Washington, DC,

in the regulatory field and has been the Company’s legal lead in these matters

for some time. Mr. Steinman handles all the domestic and international

trademark registrations for the Company and has been working with both the

EPA and FDA on the Company’s new registrations. In Canada, the Company

has also been working with Dicentra Regulatory Consultants, a highly respected

Toronto based agency, initially for work with Health Canada, but which also has

a great deal of expertise with the FDA. For specialized situations, the Company

has several other Washington based agencies, all coordinated by Mr. Steinman

to expedite registrations.

Page 2 of 4

The Company’s current FDA registration for its PureBiotic ® Solution is of

immediate interest because of the expected speed to completion. This specific

registration will increase the Company ’s market expansion opportunities

and demonstrate the benefits of the Company’s products. The comb ination of

the EPA and FDA agencies in the USA, as well as for markets around the world,

is of great importance to the Company and will provide a number of extremely

significant factors that will be covered in a products report.

It should also be noted that several other registrations have already been

obtained by the Company, including NFS approval and registration for a number

of products. The NSF approval assures consumers and regulators that the

certified products have been ri gorously tested to comply with all standards

required. In addition to other certifications and registrations normally listed on

the Company’s product labels, the Company also had previously won Green

Seal Certification for a number of the Company’s original products and with its

new trademarked name will be re-certifying a number of its products as soon

as its new USA production facility is in operation.

Martin Kepman, Chief Executive Officer, commented: "We continue to evolve

our misting solution for the mitigation of pathogens, including COVID -19.

Research is showing positive efficacy. We are now moving towards additional

certifications, including applying for FDA approval."

The Company is not making any express or implied claim that it has developed

a COVID-19 air management solution at this time.

About Manganese X Energy Corp.

Manganese X's mission is to advance its Battery Hill project into production,

with the intent of supplying value -added materials to the lithium -ion battery

and other alternative energy industries, The Company is also striving to achieve

new carbon-friendly more efficient methodologies, while processing manganese

at a lower competitive cost. The Company is the only actively publicly traded

manganese company in Canada and the US moving toward commercialization

of a manganese deposit.

Subsidiary Disruptive Battery Corp.'s special mission through its partnership

with PureBiotic AIR, to set up a primarily North American sourced and USA

based facility for its production of its patented, “USA MADE” Air Purification and

Page 3 of 4

Environmental Control Systems comprised of its Air Control Units and university

and hospital tested and proven StaBiotic Microscopic Environmental Control

Solutions that is a major breath -through in a critical range of solutions from

everything from better, cleaner and odorless air to vital, practical and incredibly

effective, totally safe and economical new methodology to vastly reduce

infections with a pure product that is safe enough to drink and yet has proven

to be far more effective than existing chemical disinfectants and cleaners.

PureBiotic Systems for its develop an HVAC (heating, ventilation and air

conditioning) air purification delivery system for cleaner and healthier air,

aiming to mi tigate COVID-19 and other contaminants on surfaces and in the

air. For more information visit the website at www.manganeseenergycorp.com.

On behalf of the Board of Directors of

MANGANESE X ENERGY CORP.

Martin Kepman

CEO and Director

Email: [email protected]

Tel: 1-514-802-1814

Cautionary Note Regarding Forward-Looking Statements:

Neither TSX Venture Exchange nor its Regulation Services Provid er (as that

term is defined in the policies of the TSX Venture Exchange) accepts

responsibility for the adequacy or accuracy of this release.

This news release contains "forward-looking information" including statements

with respect to the future explora tion performance of the Company. This

forward-looking information involves known and unknown risks, uncertainties

and other factors which may cause the actual results, performance or

achievements of the Company to be materially different from any future results,

performance or achievements of the Company, expressed or implied by such

forward-looking statements. These risks, as well as others, are disclosed within

the Company's filing on SEDAR, which investors are encouraged to review prior

to any transaction involving the securities of the Company.

Forward-looking information contained herein is provided as of the date of this

news release and the Company disclaims any obligation, other than as required

by law, to update any forward -looking information for any reason. There can

Page 4 of 4

be no assurance that forward-looking information will prove to be accurate, and

the reader is cautioned not to place undue reliance on such forward -looking

information. We seek safe harbor.